Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs LillyDirect Foundayo

boostAGErx
Graded #183

Lower grade

vs+0.4000000000000057
LillyDirect Foundayo
Graded #174

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 66.8/100, but only just.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. boostAGErx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +2
74
72
Dose & formulationboostAGErx +18
77
59
Clinical oversightLillyDirect Foundayo +4
74
78
Labs & monitoringEven
52
52
FulfillmentLillyDirect Foundayo +11
69
80
Contract termsLillyDirect Foundayo +30
25
55
boostAGErx · left barLillyDirect Foundayo · right bar

The numbers

MetricboostAGErxLillyDirect Foundayo
WeighScore66.8/10067.2/100
GradeCC
Scorecard rank#183#174
Semaglutide$95/mo (starting dose, compounded)Not disclosed
Tirzepatide$95/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
LillyDirect Foundayo

Graded #174 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard